Ida K. Lund - Key Publications

Peer reviewed publications

T. Thurison, I.K. Lund, M. Illemann, I.J. Christensen, and G. Høyer-Hansen (2011). Urokinase-type plasminogen activator, its receptor and inhibitor as biomarkers in cancer. Matrix proteases in health and disease, Wiley-VCH STM-Books, Germany. Editor: Niels Behrendt. Accepted for publication 2011 Aug 15.

I.K. Lund, M. Illemann, T. Thurison, I.J. Christensen, and G. Høyer-Hansen (2011). uPAR as Anti-Cancer Target: Evaluation of Biomarker Potential, Histological Localization, and Antibody-Based Therapy. Curr. Drug Targets, 2011, June 27. [Epub ahead of print]. In Press.

I.K. Lund, B.S. Nielsen, K. Almholt, B. Rønø, A. Hald, M. Illemann, K.A. Green, I.J. Christensen, J. Rømer, and L.R. Lund. (2011). Concomitant lack of MMP9 and uPA disturbs physiological tissue remodeling. Dev. Biol. 358 (1), 56-67.

A. Jögi, B. Rønø, I.K. Lund, B.S. Nielsen, M. Ploug, G. Høyer-Hansen, J. Rømer, and L.R. Lund (2010). Neutralisation of uPA with a monoclonal antibody reduces plasmin formation and delays skin wound healing in tPA-deficient mice. PLoS. ONE. 5 (9), e12746.

I.K. Lund, A. Jögi, B. Rønø, M.G. Rasch, L.R. Lund, K. Almholt, H. Gårdsvoll, N. Behrendt, J. Rømer, and G. Høyer-Hansen (2008). Antibody-mediated targeting of the urokinase-type plasminogen activator proteolytic function neutralizes fibrinolysis in vivo. J. Biol. Chem. 283 (47), 32506-32515.

M.G. Rasch, J. Pass, M. Illemann, G. Høyer-Hansen, and I.K. Lund (2008). Discrimination of different forms of the murine urokinase plasminogen activator receptor on the cell surface using monoclonal antibodies. J. Immunol. Methods. 339 (1), 55-65.

G. Høyer-Hansen and I.K. Lund (2007). Urokinase receptor variants in tissue and body fluids. Adv. Clin. Chem. 44, 65-102.